241 related articles for article (PubMed ID: 27401840)
21. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
Wang YK; Shen L; Jiao X; Zhang XT
World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
[TBL] [Abstract][Full Text] [Related]
22. A study on the microheterogeneity of alpha-fetoproteins produced by yolk sac and germ cell tumors.
Yamamoto R; Ohkouchi T; Wakui Y; Minobe S; Watari H; Shimizu K; Satomura S; Sakuragi N
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):876-82. PubMed ID: 12911452
[TBL] [Abstract][Full Text] [Related]
23. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
Cushing B; Giller R; Ablin A; Cohen L; Cullen J; Hawkins E; Heifetz SA; Krailo M; Lauer SJ; Marina N; Rao PV; Rescorla F; Vinocur CD; Weetman RM; Castleberry RP
Am J Obstet Gynecol; 1999 Aug; 181(2):353-8. PubMed ID: 10454682
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of serum α-fetoprotein in ovarian yolk sac tumors: A systematic review and meta-analysis.
Guo YL; Zhang YL; Zhu JQ
Mol Clin Oncol; 2015 Jan; 3(1):125-132. PubMed ID: 25469282
[TBL] [Abstract][Full Text] [Related]
25. Mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma.
Wang Y; Zhou F; Qian Z; Qing J; Zhao M; Huang L
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S198-200. PubMed ID: 25518772
[TBL] [Abstract][Full Text] [Related]
26. Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases.
Chen J; Wang J; Cao D; Yang J; Shen K; Huang H; Shi X
Arch Gynecol Obstet; 2021 Oct; 304(4):1043-1053. PubMed ID: 33751209
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
28. Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
Fresneau B; Orbach D; Faure-Conter C; Sudour-Bonnange H; Vérité C; Gandemer V; Pasquet M; Fasola S; Rome A; Raimbault S; Martelli H; Frappaz D; Le Teuff G; Patte C
Eur J Cancer; 2018 May; 95():11-19. PubMed ID: 29604495
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of stage I pediatric testicular yolk sac tumors: a report of ten cases].
Ye YL; Qin ZK; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Chen ZF
Ai Zheng; 2008 Nov; 27(11):1226-8. PubMed ID: 19000459
[TBL] [Abstract][Full Text] [Related]
30. Conservative treatment of big yolk sac tumour of the ovary in young girl.
Beurdeley M; Gauthier T; Piguet C; Fourcade L
J Visc Surg; 2010 Aug; 147(4):e265-7. PubMed ID: 20920902
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
[TBL] [Abstract][Full Text] [Related]
32. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
33. Mucinous carcinoid as an unusual manifestation of endodermal differentiation in ovarian yolk sac tumors.
Nogales FF; Buriticá C; Regauer S; González T
Am J Surg Pathol; 2005 Sep; 29(9):1247-51. PubMed ID: 16096416
[TBL] [Abstract][Full Text] [Related]
34. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
Wang R; Li J; Xu D; Li R; Gong P
Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
[TBL] [Abstract][Full Text] [Related]
35. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T
Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041
[TBL] [Abstract][Full Text] [Related]
36. Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy.
Murphy BA; Motzer RJ; Mazumdar M; Vlamis V; Nisselbaum J; Bajorin D; Bosl GJ
Cancer; 1994 May; 73(10):2520-6. PubMed ID: 7513603
[TBL] [Abstract][Full Text] [Related]
37. Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary.
Rebischung C; Pautier P; Morice P; Lhomme C; Duvillard P
Gynecol Oncol; 2000 Apr; 77(1):203-5. PubMed ID: 10739713
[TBL] [Abstract][Full Text] [Related]
38. Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
Tran TA; Ortiz HB; Holloway RW; Bigsby GE; Finkler NJ
Int J Gynecol Pathol; 2007 Jan; 26(1):66-70. PubMed ID: 17197899
[TBL] [Abstract][Full Text] [Related]
39. Endodermal sinus tumor in children.
Davidoff AM; Hebra A; Bunin N; Shochat SJ; Schnaufer L
J Pediatr Surg; 1996 Aug; 31(8):1075-8; discussion 1078-9. PubMed ID: 8863237
[TBL] [Abstract][Full Text] [Related]
40. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
